Mylan settles EpiPen Medicaid rebate case for $465M, stock jumps
Mylan settled with the U.S. Department of Justice to head off potential Medicaid liability claims by federal and state governments.
Now, the gloves are off in the EpiPen saga
The maker of EpiPen, the life-saving auto-injector for anaphylaxis, is under fire for exorbitant price hikes so much so that even Martin Shkreli called Mylan out for price-gouging last week.
presented by
10 Top-Rated Companies That Provide Medical Interpretation Services
The health care sector is constantly operating, so patient miscommunication can occur at any time. Find out the top-rated companies that provide medical interpretation services.